156 related articles for article (PubMed ID: 23023232)
1. HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells.
Mardente S; Mari E; Consorti F; Di Gioia C; Negri R; Etna M; Zicari A; Antonaci A
Oncol Rep; 2012 Dec; 28(6):2285-9. PubMed ID: 23023232
[TBL] [Abstract][Full Text] [Related]
2. MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma.
Ding C; Yu H; Shi C; Shi T; Qin H; Cui Y
Biomed Pharmacother; 2019 Feb; 110():528-536. PubMed ID: 30530288
[TBL] [Abstract][Full Text] [Related]
3. HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer.
Mardente S; Mari E; Massimi I; Fico F; Faggioni A; Pulcinelli F; Antonaci A; Zicari A
Biomed Res Int; 2015; 2015():512027. PubMed ID: 26106610
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
[TBL] [Abstract][Full Text] [Related]
5. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
6. miR-182 targets CHL1 and controls tumor growth and invasion in papillary thyroid carcinoma.
Zhu H; Fang J; Zhang J; Zhao Z; Liu L; Wang J; Xi Q; Gu M
Biochem Biophys Res Commun; 2014 Jul; 450(1):857-62. PubMed ID: 24971532
[TBL] [Abstract][Full Text] [Related]
7. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract][Full Text] [Related]
9. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
Xiong Y; Zhang L; Holloway AK; Wu X; Su L; Kebebew E
PLoS One; 2011; 6(10):e24717. PubMed ID: 21998631
[TBL] [Abstract][Full Text] [Related]
10. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma.
Salajegheh A; Vosgha H; Rahman MA; Amin M; Smith RA; Lam AK
Hum Pathol; 2016 May; 51():75-85. PubMed ID: 27067785
[TBL] [Abstract][Full Text] [Related]
11. The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma.
Zhao Y; Liu X; Zhong L; He M; Chen S; Wang T; Ma S
Int J Mol Med; 2015 Oct; 36(4):1097-103. PubMed ID: 26252081
[TBL] [Abstract][Full Text] [Related]
12. MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha.
Leone V; D'Angelo D; Rubio I; de Freitas PM; Federico A; Colamaio M; Pallante P; Medeiros-Neto G; Fusco A
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1388-98. PubMed ID: 21752897
[TBL] [Abstract][Full Text] [Related]
13. MIR22HG inhibits cell growth, migration and invasion through regulating the miR-24-3p/p27kip1 axis in thyroid papillary carcinomas.
Chen ZB; Cao WL; Su K; Mao M; Zeng XY; Li JH
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5851-5862. PubMed ID: 31298336
[TBL] [Abstract][Full Text] [Related]
14. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.
Qiu Z; Li H; Wang J; Sun C
Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684
[TBL] [Abstract][Full Text] [Related]
15. Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer.
Salajegheh A; Vosgha H; Md Rahman A; Amin M; Smith RA; Lam AK
J Mol Endocrinol; 2015 Dec; 55(3):183-96. PubMed ID: 26342107
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
17. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
[TBL] [Abstract][Full Text] [Related]
19. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
[TBL] [Abstract][Full Text] [Related]
20. miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells.
Luo L; Xia L; Zha B; Zuo C; Deng D; Chen M; Hu L; He Y; Dai F; Wu J; Wang C; Wang Y; Zhang Q
Biomed Pharmacother; 2018 Oct; 106():983-990. PubMed ID: 30119270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
